What is the appropriate management for a type 2 diabetic patient with a capillary blood glucose of 398 mg/dL?

Management of Type 2 Diabetic Patient with Blood Glucose 398 mg/dL

For a type 2 diabetic patient with capillary blood glucose of 398 mg/dL (22.1 mmol/L), immediately assess for ketosis and hyperosmolar state, then initiate rapid-acting insulin with aggressive hydration while targeting a glucose range of 140-180 mg/dL.

Immediate Assessment Required

A blood glucose of 398 mg/dL represents severe hyperglycemia requiring urgent evaluation for life-threatening complications:

Check for Ketosis (Critical First Step)

• Measure urine ketones or blood ketones immediately 11
• In T2D patients on insulin or with severe hyperglycemia, ketosis must be systematically investigated when glucose exceeds 297 mg/dL (16.5 mmol/L) 11

Assess for Hyperosmolar State

Look specifically for:

• Altered mental status (confusion, lethargy)
• Severe dehydration (poor skin turgor, dry mucous membranes)
• Asthenia (profound weakness)

If hyperosmolar state suspected: Obtain urgent serum electrolytes and calculated osmolality. Hyperosmolarity >320 mosmol/L requires ICU transfer 111

Treatment Algorithm Based on Ketosis Status

If Ketosis Present (Ketonuria ≥1+ or Ketonaemia >0.5 mmol/L):

• Give 6 IU ultra-rapid insulin analogue subcutaneously immediately 11
• Call duty physician
• Recheck blood glucose and ketones in 3 hours
• If ketonuria ≥2+ or ketonaemia ≥1.5 mmol/L: Transfer to ICU for IV insulin infusion 11

If No Ketosis (Ketonuria = 0, Ketonaemia <0.5 mmol/L):

• Give 6 IU ultra-rapid insulin analogue subcutaneously 11
• Initiate aggressive hydration (oral if tolerated, IV if not) 11
• Recheck blood glucose in 3 hours

Ongoing Insulin Management

Insulin therapy is the preferred treatment for managing hyperglycemia >180 mg/dL in hospitalized patients 223

For Hospitalized/Supervised Setting:

• Target glucose range: 140-180 mg/dL for most patients 223
• Implement basal-bolus insulin regimen with:
  • Basal (long-acting) insulin once daily
  • Prandial (rapid-acting) insulin with meals
  • Correction doses as needed 222

Insulin Dosing Strategy:

• Start with 0.5-1 IU/kg total daily dose (divided: half as basal, half as prandial split across 3 meals) 1
• Reduce prandial dose by half if meal intake is light 1
• Monitor capillary glucose before each meal and at bedtime 23

Critical Pitfalls to Avoid

Never use sliding-scale insulin alone as primary therapy—this is only appropriate for patients whose glucose is in target range most of the time 222

Do not delay insulin initiation in severe hyperglycemia. At glucose levels of 398 mg/dL with symptoms, insulin should be considered first-line treatment 4

Monitor for hypoglycemia during treatment intensification—check glucose more frequently (every 4-6 hours minimum if not eating, before meals if eating) 23

Outpatient Transition Considerations

Once acute hyperglycemia is controlled and patient is stable for discharge:

• Continue basal-bolus regimen if glucose control required intensive insulin during hospitalization 11
• For patients not previously on insulin with HbA1c <8%: Consider transitioning to oral agents plus basal insulin 11
• Arrange follow-up within 1-2 weeks for insulin dose adjustment 11
• If HbA1c >9% or persistent glucose >200 mg/dL: Request endocrinology consultation before discharge 11

Hydration is Essential

Severe hyperglycemia causes osmotic diuresis leading to significant fluid deficits. Adequate fluid resuscitation must accompany insulin therapy to prevent worsening dehydration and potential hyperosmolar complications 125